BlaCTX-M-carrying Escherichia coli of the O25b ST131 clonal group have emerged in China

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 2, 2011, Pages 228-231

  Zong, Zhiyong ^a,b   Yu, Rujia ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Escherichia coli; Extended spectrum lactamase; Plasmid

Indexed keywords

ASPARAGINE; ASPARTIC ACID; BETA LACTAMASE CTX M; CEFOTAXIME; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SERINE; TYROSINE; BETA LACTAMASE; O ANTIGEN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; ESCHERICHIA COLI; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; BACTERIAL GENE; BACTERIUM IDENTIFICATION; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; MULTILOCUS SEQUENCE TYPING;

BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CHINA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENES, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; O ANTIGENS; PLASMIDS;

EID: 78651416795     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.10.007     Document Type: Article

References (25)

1. Aubert D., Poirel L., Chevalier J., Leotard S., Pages J.M., Nordmann P Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2001, 45:1615-1620.
2. Cagnacci S., Gualco L., Debbia E., Schito G.C., Marchese A European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 2008, 46:2605-2612.
3. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., Threlfall E.J Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 2005, 63:219-228.
4. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J. Antimicrob. Chemother. 2007, 60:394-397.
5. Cerquetti M., Giufre M., Garcia-Fernandez A., Accogli M., Fortini D., Luzzi I., Carattoli A Ciprofloxacin-resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy. Clin. Microbiol. Infect. 2010, 2010. (published advance Jan). 10.1111/j.1469-0691.2010.03162.x.
6. Clermont O., Bonacorsi S., Bingen E Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000, 66:4555-4558.
7. Clermont O., Lavollay M., Vimont S., Deschamps C., Forestier C., Branger C., Denamur E., Arlet G The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 2008, 61:1024-1028.
8. Clermont O., Dhanji H., Upton M., authors other Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 2009, 64:274-277.
9. Coque T.M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Canton R., Nordmann P Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg. Infect. Dis. 2008, 14:195-200.
10. Johnson J.R., Menard M., Johnston B., Kuskowski M.A., Nichol K., Zhanel G.G Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 2009, 53:2733-2739.
11. Johnson J.R., Johnston B., Clabots C., Kuskowski M.A., Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 2010, 51:286-294.
12. Leflon-Guibout V., Blanco J., Amaqdouf K., Mora A., Guize L., Nicolas-Chanoine M.H Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J. Clin. Microbiol. 2008, 46:3900-3905.
13. Lindgren P.K., Karlsson A., Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob. Agents Chemother. 2003, 47:3222-3232.
14. Maynard C., Bekal S., Sanschagrin F., Levesque R.C., Brousseau R., Masson L., Lariviere S., Harel J Heterogeneity among virulence and antimicrobial resistance gene profiles of extraintestinal Escherichia coli isolates of animal and human origin. J. Clin. Microbiol. 2004, 42:5444-5452.
15. Mulvey M.R., Soule G., Boyd D., Demczuk W., Ahmed R Characterization of the first extended-spectrum β-lactamase-producing Salmonella isolate identified in Canada. J. Clin. Microbiol. 2003, 41:460-462.
16. Nicolas-Chanoine M.H., Blanco J., Leflon-Guibout V., authors other Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 2008, 61:273-281.
17. Novais A., Baquero F., Machado E., Canton R., Peixe L., Coque T.M International spread and persistence of TEM-24 is caused by the confluence of highly penetrating enterobacteriaceae clones and an IncA/C2 plasmid containing Tn1696::Tn1 and IS5075-Tn21. Antimicrob. Agents Chemother. 2010, 54:825-834.
18. Osborn A.M., da Silva Tatley F.M., Steyn L.M., Pickup R.W., Saunders J.R Mosaic plasmids and mosaic replicons: evolutionary lessons from the analysis of genetic diversity in IncFII-related replicons. Microbiology 2000, 146:2267-2275.
19. Oteo J., Diestra K., Juan C., authors other Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int. J. Antimicrob. Agents. 2009, 34:173-176.
20. Oteo J., Cercenado E., Cuevas O., Bautista V., Delgado-Iribarren A., Orden B., Perez-Vazquez M., Garcia-Cobos S., Campos J AmpC β-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131. Diagn. Microbiol. Infect. Dis. 2010, 67:270-276.
21. Pitout J.D., Gregson D.B., Campbell L., Laupland K.B Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli causing bacteraemia in the Calgary Health Region 2000-07: the emergence of clone ST131 as a cause of community-acquired infections. Antimicrob. Agents Chemother. 2009, 53:2846-2851.
22. Sidjabat H.E., Paterson D.L., Adams-Haduch J.M., Ewan L., Pasculle A.W., Muto C.A., Tian G.B., Doi Y Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob. Agents Chemother. 2009, 53:4733-4739.
23. Suzuki S., Shibata N., Yamane K., Wachino J.I., Ito K., Arakawa Y Rapid change in the prevalence of extended-spectrum β-lactamase-producing Escherichia coli in Japan by clonal spread. J. Antimicrob. Chemother. 2009, 63:72-79.
24. Yamane K., Wachino J., Suzuki S., Arakawa Y Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 2008, 52:1564-1566.
25. Zong Z., Partridge S.R., Thomas L., Iredell J.R Dominance of blaCTX-M within an Australian extended-spectrum β-lactamase gene pool. Antimicrob. Agents Chemother. 2008, 52:4198-4202.